[Pemphigoid gestationis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]

Ann Dermatol Venereol. 2011 Mar;138(3):264-6. doi: 10.1016/j.annder.2011.01.015.
[Article in French]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Autoantigens / immunology
  • Biopsy
  • Collagen Type XVII
  • Contraceptives, Oral, Hormonal / adverse effects
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Infant, Newborn
  • Non-Fibrillar Collagens / immunology
  • Obstetrics
  • Patient Care Team
  • Patient Education as Topic
  • Pemphigoid Gestationis / diagnosis*
  • Pemphigoid Gestationis / drug therapy*
  • Pemphigoid Gestationis / epidemiology
  • Pemphigoid Gestationis / pathology
  • Physical Examination
  • Pregnancy
  • Pregnancy Outcome
  • Recurrence
  • Serologic Tests

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Autoantigens
  • Contraceptives, Oral, Hormonal
  • Immunosuppressive Agents
  • Non-Fibrillar Collagens